Activation of transient receptor potential channel vanilloid 4 by DPP-4 (dipeptidyl peptidase-4) inhibitor vildagliptin protects against diabetic endothelial dysfunction

P Gao, L Li, X Wei, M Wang, Y Hong, H Wu, Y Shen… - …, 2020 - Am Heart Assoc
Endothelial dysfunction is an early step to the progression of cardiovascular diseases in
diabetes. Apart from their anti-diabetic action, DPP-4 (dipeptidyl peptidase-4) inhibitors also …

Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial …

P Gao, L Li, X Wei, M Wang, Y Hong… - … (Dallas, Tex.: 1979 …, 2020 - pubmed.ncbi.nlm.nih.gov
Endothelial dysfunction is an early step to the progression of cardiovascular diseases in
diabetes. Apart from their anti-diabetic action, DPP-4 (dipeptidyl peptidase-4) inhibitors also …

Endothelial Function

2019 - Am Heart Assoc
Endothelial dysfunction is an early step to the progression of cardiovascular diseases in
diabetes. Apart from their anti-diabetic action, DPP-4 (dipeptidyl peptidase-4) inhibitors also …

Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial …

P Gao, L Li, X Wei, M Wang, Y Hong, H Wu, Y Shen… - Hypertension, 2020 - cir.nii.ac.jp
抄録< jats: p> Endothelial dysfunction is an early step to the progression of cardiovascular
diseases in diabetes. Apart from their anti-diabetic action, DPP-4 (dipeptidyl peptidase-4) …

Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial …

P Gao, L Li, X Wei, M Wang, Y Hong, H Wu… - … (Dallas, Tex.: 1979), 2019 - europepmc.org
Endothelial dysfunction is an early step to the progression of cardiovascular diseases in
diabetes. Apart from their anti-diabetic action, DPP-4 (dipeptidyl peptidase-4) inhibitors also …